Improving sexual health for women with breast cancer
Systematic Intervention to Improve Sexual Dysfunction in Adjuvant Breast Cancer Patients
NA · Center Eugene Marquis · NCT06583460
This study tests whether regular sexual health support can help women with localized breast cancer feel better about their sexual health compared to only getting help when they ask for it.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | Center Eugene Marquis (other) |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Rennes, Brittany Region) |
| Trial ID | NCT06583460 on ClinicalTrials.gov |
What this trial studies
This clinical trial aims to compare the effectiveness of early, systematic oncosexological care against on-demand care in enhancing the sexual health of women diagnosed with localized breast cancer. Participants will be evaluated at baseline and 18 months after starting their cancer treatment, with additional assessments at 4, 8, and 12 months for those receiving extra oncosexological support. The study focuses on providing comprehensive sexual health support tailored to the needs of women undergoing treatment for breast cancer.
Who should consider this trial
Good fit: Ideal candidates for this study are women aged 18 and older with localized breast cancer who are beginning treatment involving surgical resection.
Not a fit: Patients with a history of cancer in the last five years or those who are pregnant or breastfeeding may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve the sexual health and quality of life for women undergoing treatment for breast cancer.
How similar studies have performed: Other studies have shown promising results with systematic approaches to sexual health care in cancer patients, indicating potential for success in this trial.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Women ≥ 18 years (menopausal or not), * Localized breast cancer with or without lymph node involvement, * Initial treatment starting with surgical resection, whatever the associated therapy (chemotherapy, radiotherapy, hormone therapy, monoclonal antibody, conjugated drug antibody, targeted therapy such as cyclin and anti-PARP inhibitors, etc.), * Patient affiliated or benefiting from the social security system, * Patient informed and informed consent signed. Exclusion Criteria: * History of cancer (except squamous cell carcinoma or basal cell carcinoma) in the last five years, * Pregnant or breast-feeding women, * Patients deprived of their liberty, under guardianship or curatorship and all other administrative safeguards, * Patients unable to comply with the study schedule for social, medical or psychological reasons.
Where this trial is running
Rennes, Brittany Region
- Centre de Lutte contre le Cancer Eugène Marquis — Rennes, Brittany Region, France (RECRUITING)
Study contacts
- Principal investigator: Claudia Lefeuvre-Plesse, MD — Centre de Lutte Contre Le cancer Eugène Marquis
- Study coordinator: Marion Trochet
- Email: m.trochet@rennes.unicancer.fr
- Phone: 0299253165
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Breast Cancer Female, Localized Cancer, Sexual dysfunction